WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s share price traded up 42.4% on Thursday . The stock traded as high as $13.1350 and last traded at $18.8850. 465 shares traded hands during mid-day trading, a decline of 51% from the average session volume of 948 shares. The stock had previously closed at $13.2623.
WisdomTree BioRevolution Fund Stock Performance
The stock has a market cap of $2.83 million, a PE ratio of 17.03 and a beta of 1.01. The company’s 50-day moving average price is $17.40 and its 200 day moving average price is $16.02.
Institutional Investors Weigh In On WisdomTree BioRevolution Fund
An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC boosted its position in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,864 shares of the company’s stock after acquiring an additional 5,306 shares during the quarter. Jane Street Group LLC owned 11.24% of WisdomTree BioRevolution Fund worth $231,000 at the end of the most recent quarter.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Featured Articles
- Five stocks we like better than WisdomTree BioRevolution Fund
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump’s AI Secret: 100X Faster Than Nvidia
- Trump Planning to Use Public Law 63-43: Prepare Now
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
